Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2011
05/04/2011EP2315521A1 Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine h 4 receptor
05/04/2011EP2185536B1 Herbicide triazolylpyridine ketones
05/04/2011EP2044036B1 [4,5']bipyrimidinyl-6,4'-diamine derivatives as protein kinase inhbitors
05/04/2011EP1981876B1 Triazoloanilinopyrimidine derivatives for use as antiviral agents
05/04/2011EP1802372B1 Cgrp receptor antagonists
05/04/2011EP1794122B1 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase i
05/04/2011EP1633724B1 Phthalazinone derivatives
05/04/2011EP1607395B1 Process for the preparation of amorphous rabeprazole sodium salt
05/04/2011EP1414439B1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
05/04/2011EP1373261B1 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
05/04/2011EP1317448B2 Pyrazole compounds useful as protein kinase inhibitors
05/04/2011EP1252156B1 Blockade of voltage dependent sodium channels
05/04/2011CN1968949B Proline derivatives and their use as dipeptidyl peptidase IV inhibitors
05/04/2011CN1956954B Novel androgens
05/04/2011CN102046618A Hydroxyquinoxalinecarboxamide derivative
05/04/2011CN102046617A Intermediates and a process employing the intermediates for the preparation of (3-trifluoromethylsulfonyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2ylamino)-phenyl]-benzamide
05/04/2011CN102046609A Pyrimidine derivative having cell-protecting activity and use thereof
05/04/2011CN102046608A 3,4-dihydropyrimidine TRPA1 antagonists
05/04/2011CN102046601A Benzene or thiophene derivative and use thereof as VAP-1 inhibitor
05/04/2011CN102046597A (hetero-)aryl cyclohexane derivatives
05/04/2011CN102040591A 7-phenyl quinolone compounds
05/04/2011CN102040590A Process for the preparing 3-(4-piperidinyl)- 2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-one
05/04/2011CN102040589A Condensed-cyclic compound and organic light emitting diode
05/04/2011CN102040588A Tyrosine kinase inhibitor and medicinal application thereof in treating malignant tumor
05/04/2011CN102040587A Preparation method of imatinib mesylate
05/04/2011CN102040558A Substituted bicyclo(3,3,1)nonane ether compound and application thereof
05/04/2011CN101627999B Balofloxacin composition, preparation method thereof and synthesis method of material medicament
05/04/2011CN101565402B Indeno isoquinolone compound and preparation method and medical application thereof
05/04/2011CN101180278B 2-amino-4-phenylquinazoline derivates and their use as HSP90 modulators
05/04/2011CN101142180B Pyrrolidine derivatives as histamine h3 receptor antagonists
05/04/2011CN101103005B Quinazoline derivatives, preparation methods and uses thereof
05/03/2011US7935852 Fluoridation method
05/03/2011US7935832 Pyrrole and isoindole carboxamide derivatives as P2X7 modulators
05/03/2011US7935825 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
05/03/2011US7935824 Ethylenediamine derivatives
05/03/2011US7935815 Imidazoyl pyridine compounds and salts thereof
05/03/2011US7935716 Carboxamide compound and use of the same
05/03/2011US7935707 Imidazole derivatives
05/03/2011US7935703 Piperazines and piperidines as Mglur5 potentiators
05/03/2011US7935698 Heteroaryl-hydrazone compounds
05/03/2011CA2528920C Cyclo(hetero)alkenyl compounds useful for treating pain
05/03/2011CA2489824C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases
05/03/2011CA2476343C 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
05/03/2011CA2440438C Heterocyclic compounds
05/03/2011CA2439709C Aryl and heteroaryl urea chki inhibitors for use as radiosensitizers and chemosensitizers
05/03/2011CA2415010C Propane-1,3-dione derivatives useful as gnrh receptor antagonist
04/2011
04/28/2011WO2011049988A2 Indazoles to treat flaviviridae virus infection
04/28/2011WO2011049987A2 Azaindazoles to treat flaviviridae virus infection
04/28/2011WO2011049917A1 Indazole and pyrazolopyridine compounds as ccr1 receptor antagonists
04/28/2011WO2011049520A1 Adamantyl iminocarbonyl-substituted pyrimidines as inhibitors of 1 1 betahsd1
04/28/2011WO2011049474A1 Salts of imatinib with tartaric acids
04/28/2011WO2011049274A1 Imidazole derivatives and compositions for treating melanoma
04/28/2011WO2011049232A1 Diaryltriazole derivative as insecticide, miticide, nematicide or soil pesticide
04/28/2011WO2011049226A1 Metal complex, polymer, and element obtained using same
04/28/2011WO2011049213A1 Fused heterocyclic compound and thrombopoietin receptor activator
04/28/2011WO2011049127A1 5-hydroxypyrimidine-4-carboxamide derivative having hydrocarbon ring group
04/28/2011WO2011049126A1 5-hydroxypyrimidine-4-carboxamide derivative
04/28/2011WO2011048525A1 Novel heteroaryl imidazoles and heteroaryl triazoles as gamma-secretase modulators
04/28/2011WO2011048032A1 Diazepam derivatives as modulators of chemokine receptors
04/28/2011WO2011047432A1 Fused ring analogues of anti-fibrotic agents
04/28/2011WO2011017334A3 Mesoionic pesticides
04/28/2011WO2011009084A3 Benzimidazole analogues for the treatment or prevention of flavivirus infections
04/28/2011WO2011002103A3 A cycloalkane derivative
04/28/2011WO2010132873A3 Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase
04/28/2011WO2010038086A8 P38 map kinase inhibitors
04/28/2011US20110098468 Nk1 antagonists
04/28/2011US20110098467 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
04/28/2011US20110098320 Lactam Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1
04/28/2011US20110098318 Farnesyl protein transferase inhibitors for treating breast cancer
04/28/2011US20110098310 Novel compounds, use and preparation thereof
04/28/2011US20110098301 Pyrimidine Derivatives for Treatment of Hyperproliferative Disorders
04/28/2011US20110098299 Spirolactam derivatives and uses of same
04/28/2011US20110098296 Thiazole And Oxazole Kinase Inhibitors
04/28/2011US20110098293 Inhibitors of Protein Tyrosine Kinase Activity
04/28/2011US20110098288 Sulfonamides as zap-70 inhibitors
04/28/2011US20110098287 Novel Heteroaromatic Amides And Thioamides As Pesticides
04/28/2011US20110098285 Bicyclic-substituted amines as histamine-3 receptor ligands
04/28/2011US20110098283 3-cinnolinecarboxamide derivatives and their use for treating cancer
04/28/2011US20110098280 2,4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
04/28/2011US20110098277 Fab I Inhibitors
04/28/2011US20110098276 Oxycarbamoyl compounds and the use thereof
04/28/2011US20110098275 5-alkynyl-pyridines
04/28/2011US20110098272 Novel Compounds As Casein Kinase Inhibitors
04/28/2011US20110098269 Substituted Pyridazinone Derivatives as Histamine-3 (H3) Receptor Ligands
04/28/2011US20110098248 Modulators of toll-like receptors
04/28/2011US20110097735 Fluorescent pyrene compounds
04/28/2011US20110097315 Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1H-quinolin-2-one and salts thereof, useful in the treatment of cancer
04/28/2011DE102009043260A1 Pyridinyl-imidazolonderivate Pyridinyl-imidazolone derivatives
04/28/2011CA2780533A1 5-hydroxypyrimidine-4-carboxamide derivative
04/28/2011CA2779298A1 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
04/28/2011CA2779292A1 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
04/28/2011CA2778060A1 Indazole and pyrazolopyridine compounds as ccr1 receptor antagonists
04/28/2011CA2776914A1 Diazepan derivatives as modulators of chemokine receptors
04/28/2011CA2776480A1 Novel heteroaryl imidazoles and heteroaryl triazoles as gamma-secretase modulators
04/27/2011EP2314593A1 Platelet ADP receptor inhibitors
04/27/2011EP2314585A1 Condensed benzamide compounds as inhibitors of vanilloid receptor subtype 1 (VR1) activity
04/27/2011EP2314582A1 Heterocyclic compounds as antiviral agents
04/27/2011EP2314578A1 Cinchonidine salt of (4S,5S)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-4,5-dihydro-1H-pyrazole-3-carboxylic acid, useful as intermediate in the preparation of cannabinoid CB1 neutral antagonists
04/27/2011EP2314575A1 Novel indole derivative having carbamoyl group, ureide group and substituted oxy group
04/27/2011EP2313395A1 Pyridone and pyridazone analogues as gpr119 modulators